Comparison of serum human Klotho levels and thiol/disulfide homeostasis in women with polycystic ovary syndrome and in healthy women.

[1]  A. Siejka,et al.  Serum β-Klotho concentrations are increased in women with polycystic ovary syndrome. , 2020, Cytokine.

[2]  Ö. Erel,et al.  Increased oxidative stress is associated with thiol/disulphide homeostasis in clomiphene citrate resistant polycystic ovary syndrome , 2020, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[3]  M. Banaszkiewicz,et al.  Klotho protein contributes to cardioprotection during ischaemia/reperfusion injury , 2020, Journal of cellular and molecular medicine.

[4]  F. Amaro-Gahete,et al.  Relationship between plasma S-Klotho and cardiometabolic risk in sedentary adults , 2020, Aging.

[5]  S. Neşelioğlu,et al.  The association of dynamic thiol-disulfide homeostasis and inflammatory markers in patients with polycystic ovary syndrome. , 2020, Taiwanese journal of obstetrics & gynecology.

[6]  Z. Kamenov,et al.  Fibroblast growth factor 23 and 25(OH)D levels are related to abdominal obesity and cardiovascular risk in patients with polycystic ovarian syndrome , 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[7]  A. Ashworth,et al.  Klotho: A Major Shareholder in Vascular Aging Enterprises , 2019, International journal of molecular sciences.

[8]  B. Dołęgowska,et al.  FGF19 subfamily members: FGF19 and FGF21 , 2019, Journal of Physiology and Biochemistry.

[9]  Ö. Erel,et al.  The Role of Follicular Fluid Thiol/Disulphide Homeostasis in Polycystic Ovary Syndrome , 2018, Balkan medical journal.

[10]  Jun-cheng Tang,et al.  Abnormality of Klotho Signaling Is Involved in Polycystic Ovary Syndrome , 2018, Reproductive Sciences.

[11]  D. Panagiotakos,et al.  Visceral adiposity index and 10-year cardiovascular disease incidence: The ATTICA study. , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[12]  S. Neşelioğlu,et al.  Dynamic Thiol-Disulphide Status in Polycystic Ovary Syndrome and Its Association with the Pathogenesis of the Disease , 2016, Gynecologic and Obstetric Investigation.

[13]  S. Neşelioğlu,et al.  The association of thiol/disulphide homeostasis and lipid accumulation index with cardiovascular risk factors in overweight adolescents with polycystic ovary syndrome , 2016, Clinical endocrinology.

[14]  Z. Zahiri,et al.  Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran , 2015, International journal of fertility & sterility.

[15]  J. Navarro-González,et al.  Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease , 2015, Journal of cellular and molecular medicine.

[16]  B. Ata,et al.  Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome. , 2016, Journal of the Turkish German Gynecological Association.

[17]  O. Erel,et al.  A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasis. , 2015, The American journal of emergency medicine.

[18]  A. Oguz,et al.  Low Serum Level of Klotho Is an Early Predictor of Atherosclerosis. , 2015, The Tohoku journal of experimental medicine.

[19]  O. Erel,et al.  A novel and automated assay for thiol/disulphide homeostasis. , 2014, Clinical biochemistry.

[20]  F. Azizi,et al.  The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran , 2014, Reproductive Biology and Endocrinology.

[21]  F. Lunger,et al.  Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome , 2014, Reproductive Biology and Endocrinology.

[22]  F. Azizi,et al.  Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study. , 2014, European journal of endocrinology.

[23]  M. Boshtam,et al.  Assessing body shape index as a risk predictor for cardiovascular diseases and metabolic syndrome among Iranian adults. , 2014, Nutrition.

[24]  J. Navarro-González,et al.  Reduced Klotho is associated with the presence and severity of coronary artery disease , 2013, Heart.

[25]  J. Krakauer,et al.  A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass Index , 2012, PloS one.

[26]  T. Pieber,et al.  The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. , 2011, The Journal of clinical endocrinology and metabolism.

[27]  E. Matteucci,et al.  Thiol Signalling Network with an Eye to Diabetes , 2010, Molecules.

[28]  P. Spritzer,et al.  Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. , 2009, Human reproduction.

[29]  H. Kahn.  Correction: The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison , 2006, BMC Cardiovascular Disorders.

[30]  R. Nagai,et al.  Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. , 1998, Biochemical and biophysical research communications.